or Try an Advanced Search...

    Technical Analysis for FH - Filament Health Corp

    Grade Last Price % Change Price Change
    F 0.038 -15.56% -0.007
    FH closed down 15.56 percent on Thursday, November 21, 2024, on 39 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical FH trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    Stochastic Sell Signal Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Weak + Overbought Other 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    20 DMA Support Bullish -15.56%
    50 DMA Support Bullish -15.56%
    Older End-of-Day Signals for FH ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support 2 days ago
    20 DMA Support 2 days ago
    10 DMA Support 2 days ago
    Down 1 ATR 2 days ago
    Down 5% 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    FH Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Entheogens Drug Development Ayahuasca Drug Discovery Serotonin Receptor Agonists

    Is FH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.2
    52 Week Low 0.03
    Average Volume 45,980
    200-Day Moving Average 0.054
    50-Day Moving Average 0.040
    20-Day Moving Average 0.035
    10-Day Moving Average 0.036
    Average True Range 0.006
    RSI (14) 47.92
    ADX 12.38
    +DI 22.783
    -DI 17.284
    Chandelier Exit (Long, 3 ATRs) 0.026
    Chandelier Exit (Short, 3 ATRs) 0.049
    Upper Bollinger Bands 0.044
    Lower Bollinger Band 0.027
    Percent B (%b) 0.65
    BandWidth 49.153
    MACD Line 0.000
    MACD Signal Line -0.001
    MACD Histogram 0.0014
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.053
    Resistance 3 (R3) 0.054 0.049 0.051
    Resistance 2 (R2) 0.049 0.046 0.049 0.050
    Resistance 1 (R1) 0.044 0.043 0.042 0.043 0.049
    Pivot Point 0.039 0.039 0.038 0.039 0.039
    Support 1 (S1) 0.034 0.036 0.032 0.033 0.027
    Support 2 (S2) 0.029 0.033 0.029 0.026
    Support 3 (S3) 0.024 0.029 0.026
    Support 4 (S4) 0.023